This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Betiatide
- DrugBank Accession Number
- DB14082
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
Structure for Betiatide (DB14082)
- Weight
- Average: 367.38
Monoisotopic: 367.083806453 - Chemical Formula
- C15H17N3O6S
- Synonyms
- Betiatida
- Betiatide
- External IDs
- MP 600
- MP-600
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Technescan MAG3 Injection, powder, lyophilized, for solution 1 mg/1 Intravenous Curium US LLC 1990-06-15 Not applicable US 
TechneScan MAG3 Injection, powder, lyophilized, for solution 1 mg/1 Intravenous Mallinckrodt 1990-06-15 2017-07-01 US TECHNETIUM Tc 99m MERTIATIDE Injection, powder, lyophilized, for solution 1 mg/1 Intravenous Jubilant DraxImage Inc., dba Jubilant Radiopharma 2023-03-31 Not applicable US - Generic Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Kit for the Preparation of Technetium Tc99m Mertiatide Injection, powder, lyophilized, for solution 1 mg/1 Intravenous Sun Pharmaceutical Industries, Inc. 2019-09-02 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 9NV2SR34P8
- CAS number
- 103725-47-9
- InChI Key
- VDPYMEBVIDZKMD-UHFFFAOYSA-N
- InChI
- InChI=1S/C15H17N3O6S/c19-11(16-6-12(20)18-8-14(22)23)7-17-13(21)9-25-15(24)10-4-2-1-3-5-10/h1-5H,6-9H2,(H,16,19)(H,17,21)(H,18,20)(H,22,23)
- IUPAC Name
- 2-(2-{2-[2-(benzoylsulfanyl)acetamido]acetamido}acetamido)acetic acid
- SMILES
- OC(=O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)C1=CC=CC=C1
References
- General References
- DailyMed Label: KIT FOR THE PREPARATION OF TECHNETIUM TC99M MERTIATIDE [Link]
- External Links
- ChemSpider
- 161231
- 194098
- ChEBI
- 136015
- ChEMBL
- CHEMBL3183117
- ZINC
- ZINC000006095847
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Kit Intravenous Injection, powder, lyophilized, for solution Intravenous 1 mg Injection, powder, for solution Intravenous Injection, powder, lyophilized, for solution Intravenous 1 mg/1 Injection, powder, for solution Intravenous 1 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.107 mg/mL ALOGPS logP -0.36 ALOGPS logP -1.4 Chemaxon logS -3.5 ALOGPS pKa (Strongest Acidic) 3.64 Chemaxon pKa (Strongest Basic) -4.5 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 141.67 Å2 Chemaxon Rotatable Bond Count 10 Chemaxon Refractivity 89.02 m3·mol-1 Chemaxon Polarizability 35.47 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at June 17, 2018 22:12 / Updated at February 21, 2021 18:54